Zepp Health Corporation
ZEPP · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 26.3% | 52.6% | -35.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38.2% | 36.2% | 37.3% | 36.8% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1.2% | -8.5% | -46.5% | -31% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -2.1% | -13% | -51.2% | -62% |
| EPS Diluted | -4.56 | -14 | -35.76 | -66.96 |
| % Growth | 67.4% | 60.9% | 46.6% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |